These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36869794)

  • 41. Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.
    Baker D; Sevak S; Callahan RE; Czako PF; Lloyd LR; Nagar S
    Am J Surg; 2019 Jan; 217(1):146-151. PubMed ID: 29929906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA.
    Sharma A; Marshall TS; Khan SS; Johns B
    Clin Drug Investig; 2014 Feb; 34(2):107-15. PubMed ID: 24214232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Subtotal Parathyroidectomy on Clinical Parameters and Quality of Life in Hemodialysis Patients with Secondary Hyperparathyroidism.
    El-Kholey MMAE; Ibrahim GES; Elshahat OI; El-Kannishy G
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):367-373. PubMed ID: 31884736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis.
    Mei C; Chen N; Ding X; Yu X; Wang L; Qian J; Wang M; Jiang G; Li X; Hou F; Zuo L; Wang N; Liu H
    Hemodial Int; 2016 Oct; 20(4):589-600. PubMed ID: 26940692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
    Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients below age 5 years
.
    Joseph C; Shah S; Geer J; Juarez-Calderon M; Srivaths PR; Swartz SJ
    Clin Nephrol; 2019 Dec; 92(6):279-286. PubMed ID: 31587754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic kidney disease (CKD) and bone. The clinical perspective of parathyroid interventional therapy for advanced secondary hyperparathyroidism in the era of cinacalcet HCl].
    Tominaga Y
    Clin Calcium; 2009 Apr; 19(4):545-50. PubMed ID: 19329834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
    Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
    Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study.
    Tartaglione L; Rotondi S; Aucella F; Bonomini M; Caruso MR; Casino F; Cuzziol C; Farcomeni A; Filippini A; Lomonte C; Marinelli R; Rolla D; Rubino F; Seminara G; Pasquali M; Mazzaferro S;
    J Nephrol; 2023 Sep; 36(7):1947-1955. PubMed ID: 37351832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
    Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
    Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
    Zhang L; Yao L; Hua Z; Bian WJ; Li WG
    Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure.
    Orellana JM; Esteban RJ; Castilla YA; Fernández-Castillo R; Nozal-Fernández G; Esteban MA; García-Valverde M; Bravo J
    Nefrologia; 2016; 36(2):121-5. PubMed ID: 26906451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.
    Malluche HH; Monier-Faugere MC; Wang G; Frazã O JM; Charytan C; Coburn JW; Coyne DW; Kaplan MR; Baker N; McCary LC; Turner SA; Goodman WG
    Clin Nephrol; 2008 Apr; 69(4):269-78. PubMed ID: 18397701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcomes and management considerations after parathyroidectomy in the dialysis patient.
    Kakani E; Sloan D; Sawaya BP; El-Husseini A; Malluche HH; Rao M
    Semin Dial; 2019 Nov; 32(6):541-552. PubMed ID: 31313380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.
    Moreno P; Coloma A; Torregrosa JV; Montero N; Francos J; Codina S; Manonelles A; Bestard O; García-Barrasa A; Melilli E; Cruzado JM
    Clin Transplant; 2020 Aug; 34(8):e13988. PubMed ID: 32438479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary Hyperparathyroidism.
    Ma Q; Su D; Liu F; Xing H; Han X; Ma D
    Am J Nephrol; 2020; 51(1):65-73. PubMed ID: 31770758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic strategies for secondary hyperparathyroidism in dialysis patients.
    Ogata H; Koiwa F; Ito H; Kinugasa E
    Ther Apher Dial; 2006 Aug; 10(4):355-63. PubMed ID: 16911189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.